These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7697635)

  • 21. Antimetastasis gene expression and numerical chromosomal abnormalities of chromosomes 1 & 17 in serous tumours of the ovary.
    Kaya H; Evans MF; Ekicioglu G; Tuzlali S; Küllü S; Foster C
    Eur J Gynaecol Oncol; 2001; 22(3):240-2. PubMed ID: 11501783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative cytogenetic and histologic studies on early malignant transformation in mesothelial tumors of the ovary.
    Knoerr-Gaertner H; Schuhmann R; Kraus H; Uebele-Kallhardt B
    Hum Genet; 1977 Mar; 35(3):281-97. PubMed ID: 557448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
    Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
    Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trisomy 12 and K-ras-2 amplification in human ovarian tumors.
    Yang-Feng TL; Li SB; Leung WY; Carcangiu ML; Schwartz PE
    Int J Cancer; 1991 Jul; 48(5):678-81. PubMed ID: 2071229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.
    Partheen K; Levan K; Osterberg L; Helou K; Horvath G
    Genes Chromosomes Cancer; 2004 Aug; 40(4):342-8. PubMed ID: 15188458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of numerical chromosomal aberrations during progression of colorectal tumors revealed by a combined fluorescence in situ hybridization and DNA ploidy analysis of intratumoral heterogeneity.
    Katsura K; Sugihara H; Nakai S; Fujita S
    Cancer Genet Cytogenet; 1996 Sep; 90(2):146-53. PubMed ID: 8830725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microdissection-based mutational genotyping of serous borderline tumors of the ovary.
    Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD
    Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copy number aberrations in benign serous ovarian tumors: a case for reclassification?
    Hunter SM; Anglesio MS; Sharma R; Gilks CB; Melnyk N; Chiew YE; deFazio A; ; Longacre TA; Huntsman DG; Gorringe KL; Campbell IG
    Clin Cancer Res; 2011 Dec; 17(23):7273-82. PubMed ID: 21976534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
    Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
    Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of chromosome aberrations in paraffin sections of seven gonadal yolk sac tumors of childhood.
    Jenderny J; Köster E; Meyer A; Borchers O; Grote W; Harms D; Jänig U
    Hum Genet; 1995 Dec; 96(6):644-50. PubMed ID: 8522320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma.
    Hill SM; Rodgers CS; Hultén MA; Wilson AP
    Cancer Genet Cytogenet; 1984 Aug; 12(4):321-7. PubMed ID: 6744227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new application of in situ hybridization: detection of numerical and structural chromosome aberrations with a combination centromeric-telomeric DNA probe.
    van Dekken H; Bauman JG
    Cytogenet Cell Genet; 1988; 48(3):188-9. PubMed ID: 3234043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A stable marker chromosome with a cryptic centromere: evidence for centromeric sequences associated with an inverted duplication.
    Sacchi N; Magnani I; Fuhrman-Conti AM; Monard SP; Darfler M
    Cytogenet Cell Genet; 1996; 73(1-2):123-9. PubMed ID: 8646879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer.
    Bayani J; Paderova J; Murphy J; Rosen B; Zielenska M; Squire JA
    Neoplasia; 2008 Oct; 10(10):1057-65. PubMed ID: 18813350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic studies of epithelial ovarian carcinoma.
    Jenkins RB; Bartelt D; Stalboerger P; Persons D; Dahl RJ; Podratz K; Keeney G; Hartmann L
    Cancer Genet Cytogenet; 1993 Nov; 71(1):76-86. PubMed ID: 8275457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.
    Körner M; Burckhardt E; Mazzucchelli L
    J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of numerical chromosome anomalies in interphase cells of ovarian carcinomas using fluorescence in situ hybridization.
    Brock JA; Liu WH; Smith ST; Young SR
    Genes Chromosomes Cancer; 1996 Jun; 16(2):120-9. PubMed ID: 8818659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients.
    Sawyer JR; Husain M; Pravdenkova S; Krisht A; Al-Mefty O
    Cancer; 2000 Jan; 88(2):440-53. PubMed ID: 10640979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
    Dehari R; Kurman RJ; Logani S; Shih IeM
    Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A chromosome study of three ovarian tumors.
    Jenkyn DJ; McCartney AJ
    Cancer Genet Cytogenet; 1987 Jun; 26(2):327-37. PubMed ID: 3471312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.